Development of high performance liquid chromatography method for buspirone in rabbit serum: Application to pharmacokinetic study.

[1]  R. Kronstrand,et al.  Quantitation of seven low-dosage antipsychotic drugs in human postmortem blood using LC-MS-MS. , 2008, Journal of analytical toxicology.

[2]  Min-Jian Xu,et al.  Quantification of a cytochrome P450 3A4 substrate, buspirone, in human plasma by liquid chromatography-tandem mass spectrometry. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[3]  F. Péhourcq.  Rapid high-performance liquid chromatographic measurement of buspirone in human plasma after overdose. , 2004, Biomedical chromatography : BMC.

[4]  A. Zarghi,et al.  Simple high-performance liquid chromatographic determination of buspirone in human plasma. , 2004, Farmaco.

[5]  N. V. Ramakrishna,et al.  Simple, sensitive and rapid liquid chromatographic/electrospray ionization tandem mass spectrometric method for the quantification of lacidipine in human plasma. , 2004, Journal of mass spectrometry : JMS.

[6]  R. Alonso,et al.  Simultaneous determination of five 1,4-dihydropyridines in pharmaceutical formulations by high-performance liquid chromatography-amperometric detection. , 2004, Journal of chromatography. A.

[7]  María T. Martín,et al.  Development and validation of a liquid chromatographic method for determination of lacidipine residues on surfaces in the manufacture of pharmaceuticals. , 2004, Journal of chromatography. A.

[8]  Vinod P. Shah,et al.  Bioanalytical Method Validation—A Revisit with a Decade of Progress , 2000, Pharmaceutical Research.

[9]  P. L. McCormack,et al.  Lacidipine: a review of its use in the management of hypertension. , 2003, Drugs.

[10]  AC Moffat,et al.  Clarke's analysis of drugs and poisons , 2003 .

[11]  K. Verma,et al.  Determination of lacidipine from urine by HPTLC using off-line SPE. , 2002, Journal of pharmaceutical and biomedical analysis.

[12]  S. Stanley.  Equine metabolism of buspirone studied by high-performance liquid chromatography/mass spectrometry. , 2000, Journal of mass spectrometry : JMS.

[13]  K. Róna,et al.  High-performance liquid chromatographic method with coulometric detection for the determination of buspirone in human plasma by means of a column-switching technique. , 1998, Journal of chromatography. A.

[14]  M. Pellegatti,et al.  Automation and validation of the high-performance liquid chromatographic-radioimmunoassay method for the determination of lacidipine in plasma. , 1995, Journal of chromatography. B, Biomedical applications.

[15]  C. R. Lee,et al.  Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension. , 1994, Drugs.

[16]  P. Grossi,et al.  Investigation into lacidipine and related metabolites by high-performance liquid chromatography—mass spectrometry , 1993 .

[17]  P. Grossi,et al.  Ether and ester glucuronic acid conjugates of lacidipine metabolites: Mass spectrometric differentiation using thermospray and particle beam techniques , 1992 .

[18]  S. Pichini,et al.  Simultaneous high-performance liquid chromatographic analysis of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in plasma using electrochemical detection. , 1992, Journal of chromatography.

[19]  G. Bolelli,et al.  Validation of a high-performance liquid chromatographic-radioimmunoassay method for the determination of lacidipine in plasma. , 1992, Journal of chromatography.

[20]  F. Kristjánsson.  Sensitive determination of buspirone in serum by solid-phase extraction and two-dimensional high-performance liquid chromatography. , 1991, Journal of chromatography.

[21]  E. Kerns,et al.  Quantitative analysis of 1-(2-pyrimidinyl)piperazine in plasma by capillary gas chromatography-mass spectrometry. , 1986, Journal of chromatography.

[22]  R. Mayol,et al.  The relationship between buspirone bioavailability and dose in healthy subjects. , 1985, Biopharmaceutics & drug disposition.